Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On January 30, 2009, Jeremy Curtis, Vice President, Worldwide Marketing of ATS Medical, Inc. ("the Company"), was appointed to the non-executive role of Vice President of Corporate Development. As a result, Mr. Curtis is no longer an executive officer of the Company.

Item 8.01 Other Events.

On February 4, 2009 the Company issued a press release announcing that the Australian Therapeutic Goods Adminstration has granted approval for commercialization of the ATS 3f® Aortic Bioprosthesis. The full text of the press release is furnished as Exhibit 99.1 hereto and is incorporated by reference.

Item 9.01 Financial Statements and Exhibits.

The following exhibit is filed with this report:

99.1 Press Release of ATS Medical, Inc. date February 4, 2009.

---